|
offered any management strategies
( unpublished data from the Long- STEPP co-design survey ).
The physiology of menstruation is more than falling oestrogens and progestogens , followed by menstruation . Appreciating that endometrial shedding is actually an inflammatory process is helpful in terms of understanding the impact of this physiological phenomenon , why it can hurt and why it can exacerbate other pain states as well as a range of other conditions , such as chronic fatigue , asthma , irritable bowel and inflammatory bowel disease . 21
The endometrium that is shed is equivalent to the surface area of a finger and is 4-6mm thick . Although
|
Suzen A et al . Pediatric Urology Case Reports 2016 / CC BY 4.0 / bit . ly / 3NgPROE |
|||
this is a physiological and normal | ||||
process , the exact inflammatory | ||||
cytokines and prostaglandins | ||||
released and activation of white cells | ||||
vary in each individual . Many people | ||||
will experience nausea , vomiting | ||||
, diarrhoea , generalised aches and | ||||
pains , headaches and dizziness . 22 Those with chronic conditions — | ||||
such as postural orthostatic tachycardia | ||||
syndrome , chronic fatigue , | ||||
rheumatoid arthritis , diabetes and | ||||
asthma — may have exacerbation of | ||||
these and poorer control . Anaphylaxis | ||||
at the time of menses has been described . 23 Monthly endometrial shedding is no small event in biological |
terms , and while it is completely normal and natural , the process may |
Figure 5 . Vaginal polyp . |
|||
have significant side effects . | ||||
In the past , when women typically | ||||
had a later onset of menarche , | ||||
had as many as 10-15 children and | ||||
breastfed them all , this process | ||||
would have occurred fewer than 50 | ||||
times in a woman ’ s lifetime . Therefore | ||||
, we could consider menses , a bit | ||||
like childbirth , as a poorly designed | ||||
biological process which also carries | ||||
significant risks of mortality to some | ||||
individuals , especially those who | ||||
cannot access appropriate care and | ||||
intervention . | ||||
As with all pain conditions , dysmenorrhoea | ||||
is influenced by previous | ||||
traumatic events that in turn | ||||
have effects on the experience of pain . 24 Furthermore , repeated episodes of significant period pain | ||||
appear to predispose to the development |
|
of chronic pelvic pain . 25 The process of central sensitisation ( amplification of the pain response ) appears to be potentially triggered by menstruation in some , while in others , central sensitisation triggers more severe period and pelvic pain . 26
Retrograde menstruation , which occurs in more than 90 % of people , is likely to also contribute to dysmenorrhoea in some , potentially more in those with heavy menstrual
22 , 27 bleeding . Exercise , stretches and yoga can
|
Figure 6 . Rhabdomyosarcoma . A two-year-old child initially saw the GP with a painless genital swelling and no history of trauma . She received two weeks of antibiotics and was referred to a paediatrician , who referred her to a gynaecologist . |
|||
all be helpful management modalities . 28 Data are limited on the beneficial effects of diet or supplements , |
there is no evidence to support this . 29 In particular , it is important to note that these hormonal meas- |
There are a large variety of oral contraceptive pills available with different hormonal constituents . In |
same beneficial impact on reducing pain and bleeding is not achieved . 31
Some patients will have adverse
|
bleeding itself is not required . It may , however , be difficult to achieve complete amenorrhoea , and patients may |
with small sample sizes , poor report- |
ures are being offered in the setting |
those with migraines with associ- |
mood effects using oral , inject- |
need to accept that a withdrawal |
ing of methodology and inconsist- |
of troublesome menses ; final height |
ated focal neurological deficit , avoid |
able ( depot medroxyprogester- |
bleed may sometimes be required |
ency ; no studies to date demonstrate |
is already determined by the onset |
oestrogens and seek neurological |
one acetate ) and implant hormonal |
to avoid or manage breakthrough |
efficacy . |
of menarche , and there is no evi- |
input . In general , progesterone-only |
approaches ( etonogestrel ). These |
bleeding . |
If simple measures have not |
dence of any significant impact of |
approaches , including the levonorg- |
effects are often related to the spe- |
Chronic pelvic pain often devel- |
worked , then hormonal approaches |
these exogenous hormones — even |
estrel-releasing intrauterine system , |
cific progestogen , so acknowledging |
ops in the setting of untreated severe |
are usually offered , including the |
in young adolescents . In studies a |
can be used in this cohort . An IUD |
the problem and trialling a different |
dysmenorrhoea and represents a |
combined oral contraceptive pill or |
few decades ago , tall girls were given |
can be used in a menstruating ado- |
progestogen will often help . |
missed opportunity to have pre- |
progestogen-only options , includ- |
oestrogens in an attempt to limit fur- |
lescent without undertaking imaging |
Skipping a period on the contra- |
vented this problem . 25 |
ing the levonorgestrel intrauterine system . Although many adolescents , their parents and clinicians have concerns regarding the negative impact of hormones on weight , |
ther growth , with doses of 100 µ g / day , 300 µ g / day and 500 µ g / day given with minimal impact on height outcomes . 30 In comparison , oestradiol doses in most contraceptive pills |
before insertion because the achievement of menstruation is a good indicator that the uterine size will permit tolerance of an IUD . Although there is a newer , smaller levonorgestrel-re- |
ceptive pill is acceptable . The endometrium in young women using the pill continuously is thin because of the progestogenic effect . It is not the bleeding that protects the endo- |
Pain
Although endometriosis is often considered a principal cause of severe pelvic pain , there is good evidence in
|
height and bone mineral density , |
today are 30 µ g / day or 35 µ g / day . |